Deflin Gayle 4
4 · Amphastar Pharmaceuticals, Inc. · Filed May 17, 2023
Insider Transaction Report
Form 4
Deflin Gayle
Director
Transactions
- Sale
Common Stock
2023-05-15$43.15/sh−1,500$64,728→ 8,682 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.149 to $43.17, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.